| Line Item | Jun 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating expenses: | |||||||||||||||
| Research and development expenses | |||||||||||||||
| General and administrative expenses, exclusive of depreciation and amortization | |||||||||||||||
| Change in fair value of contingent consideration | — | — | |||||||||||||
| Depreciation and amortization | — | — | |||||||||||||
| Operating loss | |||||||||||||||
| Financing expense, net | — | — | |||||||||||||
| Non-Operating Income (Expense) | — | ||||||||||||||
| Gain/Loss on Investments | |||||||||||||||
| Net loss before tax | — | — | |||||||||||||
| Net loss | |||||||||||||||
| Less: Net loss attributable to non-controlling interests | |||||||||||||||
| Net loss attributable to the Company’s stockholders’ equity | |||||||||||||||
| Earnings Per Share (Basic) | — | ||||||||||||||
| Earnings Per Share (Diluted) | — |